US20080152507A1 - Infusion pump with a capacitive displacement position sensor - Google Patents
Infusion pump with a capacitive displacement position sensor Download PDFInfo
- Publication number
- US20080152507A1 US20080152507A1 US11/614,364 US61436406A US2008152507A1 US 20080152507 A1 US20080152507 A1 US 20080152507A1 US 61436406 A US61436406 A US 61436406A US 2008152507 A1 US2008152507 A1 US 2008152507A1
- Authority
- US
- United States
- Prior art keywords
- infusion pump
- capacitive
- capacitive plate
- infusion
- electrokinetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B17/00—Pumps characterised by combination with, or adaptation to, specific driving engines or motors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/14526—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons the piston being actuated by fluid pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B9/00—Piston machines or pumps characterised by the driving or driven means to or from their working members
- F04B9/08—Piston machines or pumps characterised by the driving or driven means to or from their working members the means being fluid
- F04B9/10—Piston machines or pumps characterised by the driving or driven means to or from their working members the means being fluid the fluid being liquid
- F04B9/103—Piston machines or pumps characterised by the driving or driven means to or from their working members the means being fluid the fluid being liquid having only one pumping chamber
- F04B9/107—Piston machines or pumps characterised by the driving or driven means to or from their working members the means being fluid the fluid being liquid having only one pumping chamber rectilinear movement of the pumping member in the working direction being obtained by a single-acting liquid motor, e.g. actuated in the other direction by gravity or a spring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3379—Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M2205/3389—Continuous level detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/14566—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir for receiving a piston rod of the pump
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B2201/00—Pump parameters
- F04B2201/02—Piston parameters
- F04B2201/0201—Position of the piston
Definitions
- the present invention relates, in general, to a medical devices and systems and, in particular, to infusion pumps, infusion pump systems and associated methods.
- Electrokinetic (EK) pumps provide for liquid displacement by applying an electric potential across a porous dielectric media that is filled with an ion-containing electrokinetic solution.
- Properties of the porous dielectric media and ion-containing solution e.g., permittivity of the ion-containing solution and zeta potential of the solid-liquid interface between the porous dielectric media and the ion-containing solution
- permittivity of the ion-containing solution and zeta potential of the solid-liquid interface between the porous dielectric media and the ion-containing solution are predetermined such that an electrical double-layer is formed at the solid-liquid interface.
- ions of the electrokinetic solution within the electrical double-layer migrate in response to the electric potential, transporting the bulk electrokinetic solution with them via viscous interaction.
- electrokinetic flow also known as electroosmotic flow
- displace i.e., “pump”
- U.S. patent application Ser. No. 10/322,083 United States Published Application No. 2004/0074784 filed on Dec. 17, 2002, which is hereby incorporated in full by reference.
- the electrokinetic infusion pump includes an infusion pump module, which can be configured to dispense a medicament or another treatment agent (e.g., an insulin containing infusion liquid), and an electrokinetic engine.
- the infusion pump module includes a capacitive displacement position sensor configured for sensing a dispensing state of the infusion pump module.
- the infusion pump module can include an infusion module housing and the electrokinetic engine can include a moveable partition.
- the capacitive displacement sensor includes a first capacitive element, such as a capacitive plate, disposed on the moveable partition and a second element, such as a capacitive plate, disposed on the infusion module housing.
- the capacitive displacement sensor is configured for measuring capacitance between the first capacitive element and the second capacitive element and can send a feedback signal to a closed loop controller that is indicative of the capacitance between the first and second capacitive plates.
- the first capacitive plate and the second capacitive plate each have a width of approximately 10 mm and a length of approximately 20 mm.
- a gap between the first capacitive plate and the second capacitive plate can have a dimension in the range of approximately 10-1000 micrometers.
- the electrokinetic engine includes a moveable partition and the infusion pump includes an infusion housing
- the capacitive displacement sensor is a dual capacitive displacement sensor.
- the dual capacitive displacement sensor includes a first capacitive plate and a second capacitive plate disposed on the moveable partition and a third capacitive plate and a fourth capacitive plate disposed on the infusion housing.
- the first, second, third, and fourth capacitive plates are in operative electrical contact.
- An overlap between the second and fourth capacitive plate is constant and an overlap between the first capacitive plate and the third capacitive plate is dependent on a position of the moveable partition.
- an infusion pump system in another exemplary embodiment, includes an infusion pump, for example, an electrokinetic pump, having a capacitive displacement position sensor and a closed loop controller.
- the infusion pump and closed loop controller are in operative communication and configured such that the closed loop controller can determine and control a dispensing state of the infusion pump based on a feedback signal received from the capacitive displacement position sensor.
- the infusion pump further includes an infusion pump module and an electrokinetic engine.
- the capacitive displacement sensor is configured for sensing a dispensing state of the infusion pump module.
- the infusion pump can be configured to dispense, for example, an insulin-containing infusion liquid.
- the infusion pump module can include an infusion module housing and the electrokinetic engine can include a moveable partition.
- the electrokinetic engine can also include an electrokinetic supply reservoir that is at least partially collapsible.
- the capacitive displacement sensor can include a first capacitive plate disposed on the moveable partition and a second capacitive plate disposed on the infusion module housing, and the capacitive displacement sensor can be configured for sensing a dispensing state by measuring capacitance between the first capacitive plate and the second capacitive plate.
- the first capacitive plate and the second capacitive plate each have a width of approximately 10 mm and a length of approximately 20 mm, and a gap between the first capacitive plate and the second capacitive plate has a dimension in the range of approximately 10-1000 micrometer.
- the electrokinetic engine includes a moveable partition and the capacitive displacement sensor is a dual capacitive displacement sensor that includes first, second, third, and fourth capacitive plates.
- the first, second, third, and fourth capacitive plates are in operative electrical contact and an overlap between the second and fourth capacitive plate is constant and an overlap between the first capacitive plate and the third capacitive plate is dependent on a position of the moveable partition.
- Methods for the closed loop control of an infusion pump are also provided, and in one embodiment the method can include sensing a dispensing state of an infusion pump, for example, an electrokinetic infusion pump, with a capacitive displacement position sensor and signaling the sensed dispensing state of the infusion pump to a closed loop controller via a feedback signal.
- the closed loop controller determines the dispensing state of the infusion pump based feedback signal and controls the dispensing state of the infusion pump by sending command signals from the closed loop controller to an engine driving the infusion pump. These steps can be repeated to maintain control of the electrokinetic infusion pump.
- Sensing the dispensing state can include sensing a position of a moveable partition of the electrokinetic infusion pump by the capacitive displacement sensor. Sensing the dispensing state can also include sensing the position of the moveable partition due to a change in overlap between capacitive plates of the capacitive displacement sensor.
- the dispensing state can be an infusion liquid displacement rate or an infusion liquid volume.
- the step of controlling the dispensing state can include controlling the dispensing state of an insulin containing infusion liquid.
- the capacitive displacement position sensor can be a dual capacitive displacement sensor.
- FIG. 1 is an exploded schematic illustration of an electrokinetic infusion pump system with closed loop control according to an exemplary embodiment of the present invention in a first dispense state;
- FIG. 2 is an exploded schematic illustration of the electrokinetic infusion pump system shown in FIG. 1 in a second dispense state;
- FIG. 3 is a perspective illustration of an electrokinetic infusion pump system according to another exemplary embodiment of the present invention being manually manipulated;
- FIG. 4 is a cross-sectional depiction of an electrokinetic infusion pump system according to a further exemplary embodiment of the present invention in a first dispense state;
- FIG. 5 is a cross-sectional depiction of the electrokinetic infusion pump system shown in FIG. 4 in a second dispense state;
- FIG. 6 is a perspective depiction of a portion of the electrokinetic infusion pump of the EK infusion pump system shown in FIG. 4 ;
- FIG. 7 is a perspective depiction of a portion of the electrokinetic infusion pump of the EK infusion pump system shown in FIG. 5 ;
- FIG. 8 is a perspective depiction of a portion of an electrokinetic infusion pump with capacitive displacement position sensors according to another exemplary embodiment of the present invention in a first dispense state;
- FIG. 9 is a perspective depiction of the portion of an electrokinetic infusion pump shown in FIG. 8 in a second dispense state
- FIG. 10 is a schematic drawing depicting a capacitive plate configuration of the electrokinetic infusion pump shown in FIG. 8 ;
- FIG. 11 is a schematic drawing depicting a capacitive plate configuration of the electrokinetic infusion pump shown in FIG. 9 ;
- FIG. 12 is an electrical circuit schematic depicting the analog electric circuit formed by the capacitive displacement position sensor shown in FIGS. 8-11 ;
- FIG. 13 is a flow diagram illustrating a method for the closed loop control of an electrokinetic infusion pump according to an exemplary embodiment of the present invention.
- Various exemplary methods and devices are provided for controlling the dispensing state of an infusion pump system.
- the methods and devices provide a capacitive displacement position sensor coupled with an infusion pump to control the dispensing of an infusion liquid from the infusion pump.
- FIGS. 1-2 are exploded schematic illustrations of an electrokinetic (EK) infusion pump system 100 with closed loop control according to an exemplary embodiment of the present invention.
- FIG. 1 illustrates the EK infusion pump system 100 in a first dispense state
- FIG. 2 depicts the EK infusion pump system 100 in a second dispense state.
- the EK infusion pump system 100 includes an electrokinetic (EK) infusion pump 102 and a closed loop controller 104 .
- the EK infusion pump 102 can include a capacitive displacement position sensor (not shown in FIGS. 1 and 2 ).
- the EK infusion pump 102 and the closed loop controller 104 are in operative communication such that the closed loop controller 104 can determine and control the dispensing state of the EK infusion pump 102 based on one or more feedback signals FB from the capacitive displacement position sensor.
- the EK infusion pump 102 and the closed loop controller 104 can be configured in a variety of ways.
- the infusion pump 102 and the closed loop controller 104 can be entirely separate units, partially integrated (for example, predetermined components of the EK infusion pump 102 can be integrated within the closed loop controller 104 ), or a single integrated unit.
- the EK infusion pump systems can be employed to deliver a variety of medically useful infusion liquids such as, for example, insulin for diabetes; morphine and other analgesics for pain; barbiturates and ketamine for anesthesia; anti-infective and antiviral therapies for Acquired Immune Deficiency Syndrome (AIDS); antibiotic therapies for preventing infection; bone marrow for immunodeficiency disorders, blood-borne malignancies, and solid tumors; chemotherapy for cancer; dobutamine for congestive heart failure; monoclonal antibodies and vaccines for cancer, brain natriuretic peptide for congestive heart failure, and vascular endothelial growth factor for preeclampsia.
- the delivery of such infusion liquids can be accomplished via any suitable route including subcutaneously, intravenously or intraspinally.
- the EK infusion pump 102 can also include an electrokinetic (EK) engine 106 and an infusion module 108 .
- the EK engine 106 can include an electrokinetic (EK) supply reservoir 110 , an electrokinetic (EK) porous media 112 , an electrokinetic (EK) solution receiving chamber 114 , a first electrode 116 , a second electrode 118 , and an electrokinetic (EK) solution 120 (depicted as upwardly pointing chevrons).
- the pore size of the porous media 112 can be, for example, in the range of 100 nm to 200 nm.
- the porous media 112 can have any number of pores with any pore size that allows the appropriate amount of electrokinetic solution 120 to flow through it.
- the porous media 112 can be formed of any suitable material including, by way of non-limiting example, Durapore Z PVDF membrane material available from Millipore, Inc. USA.
- EK solution 120 can be any suitable EK solution including, but not limited to, 10 mM TRIS/HCl at a neutral pH.
- the infusion module 108 can include the EK solution receiving chamber 114 (which is also considered part of the EK engine 106 ), an infusion module housing 122 , a movable partition 124 , an infusion reservoir 126 , an infusion reservoir outlet 128 , and an infusion liquid 130 (depicted as dotted shading). Although the capacitive displacement position sensor of the infusion module 108 is not depicted in FIGS. 1 and 2 , the feedback signal FB between the capacitive displacement position sensor and the closed loop controller 104 is shown.
- the closed loop controller 104 can include a voltage source 132 and is configured to receive the feedback signal FB from the capacitive displacement sensor and to be in electrical communication with the first and second electrodes 116 and 118 .
- the EK engine 106 , the infusion module 108 , and the closed loop controller 104 can be integrated into a single assembly, into multiple assemblies, or can be separate units.
- the EK engine 106 provides the driving force for displacing (pumping) the infusion liquid 130 from the infusion module 108 .
- a voltage difference is established across the EK porous media 112 by the application of an electrical potential between the first electrode 116 and the second electrode 118 .
- This electrical potential results in an electrokinetic pumping of the EK solution 120 from the EK supply reservoir 110 , through the EK porous media 112 , and into the EK solution receiving chamber 114 .
- the moveable partition 124 As the electrokinetic solution receiving chamber 114 receives the EK solution 120 , the moveable partition 124 is forced to move in the direction of arrows ⁇ l, shown in FIGS. 1-2 . Such movement is evident by a comparison of the first dispense state shown in FIG. 1 to the second dispense state shown in FIG. 2 . As the moveable partition 124 moves in the direction of ⁇ l, the infusion liquid 130 is displaced (i.e., “pumped”) out of the infusion reservoir 126 and through the infusion reservoir outlet 128 in the direction of arrow ⁇ l.
- the EK engine 106 can continue to displace the EK solution 120 until the moveable partition 124 reaches a predetermined point near the infusion reservoir outlet 128 , for example, a point just proximal of the infusion reservoir outlet 128 , thereby displacing a predetermined amount (e.g., essentially all) of the infusion liquid 130 from the infusion reservoir 126 .
- a predetermined amount e.g., essentially all
- the second dispensing state represented by FIG. 2 is achieved by electrokinetically displacing (i.e., pumping or dispelling) a portion of the infusion liquid 130 that is present within the infusion reservoir 126 in the first dispensing state represented by FIG. 1 .
- the rate of displacement of the infusion liquid 130 from the infusion reservoir 126 is directly proportional to the rate at which the EK solution 120 is pumped from the EK supply reservoir 110 into the EK solution receiving chamber 114 .
- the proportionality between the rate of displacement of the infusion liquid 130 (such as an insulin containing infusion liquid) and the rate at which the EK solution 120 is pumped can be, for example, in the range of 1:1 to 4:1.
- the rate at which the EK solution 120 is pumped from the EK supply reservoir 110 is a function of the voltage and current applied by the first electrode 116 and the second electrode 118 and various electro-physical properties of the EK porous media 112 and the EK solution 120 (such as, for example, zeta potential, permittivity of the EK solution and viscosity of the EK solution).
- features disclosed herein are applicable to a variety of electrokinetic infusion pump systems, including, for example, the electrokinetic infusion pumps and electrokinetic infusion pump systems of the type disclosed in U.S. patent application Ser. No. 11/532,587, filed Sep. 18, 2006, entitled “Electrokinetic Infusion Pump System,” which is incorporated herein in its entirety.
- features disclosed herein can be used in combination with electrokinetic infusion pump systems of the type disclosed in U.S. patent application Ser. No. 11/532,587, as well as with features of electrokinetic infusion pumps as disclosed in U.S. patent application Ser. No. 11/532,691, filed Sep. 18, 2006, entitled “Malfunction Detection With Derivative Calculation,” and U.S. patent application Ser. No. 11/614,211, filed Dec. 21, 2006, entitled “Malfunction Detection In Infusion Pumps,” both of which are likewise incorporated herein in their entirety.
- EK engines including materials, designs, operation and methods of manufacturing, are included in U.S. patent application Ser. No. 10/322,083 (United States Published Application No. 2004/0074784) filed on Dec. 17, 2002, which has been incorporated by reference.
- a particular EK engine is depicted in a simplified manner in FIGS. 1 and 2
- any suitable EK engine can be employed in embodiments of the present invention including, but not limited to, the EK engines described in the aforementioned U.S. patent application Ser. No. 10/322,083 and EK engines that substitute a media with a microchannel(s) for the aforementioned porous media.
- the capacitive displacement position sensor of EK infusion pump 102 is configured to sense (determine) the position of the moveable partition 124 . Based on the sensed position of the moveable partition 124 (as communicated by feedback signal FB), the closed loop controller 104 can determine the dispensing state (e.g., the displacement position of the moveable partition 124 at any given time and/or as a function of time, the rate of displacement of the infusion liquid 130 from infusion reservoir 126 , the rate at which the EK solution 120 is pumped from the EK supply reservoir 110 to the EK solution receiving chamber 114 , and the volume of dispensed EK solution).
- the dispensing state e.g., the displacement position of the moveable partition 124 at any given time and/or as a function of time, the rate of displacement of the infusion liquid 130 from infusion reservoir 126 , the rate at which the EK solution 120 is pumped from the EK supply reservoir 110 to the EK solution receiving chamber 114 , and the volume of dispensed
- the closed loop controller 104 controls (i.e., can command and manage) the dispensing state by, for example, (i) adjusting the voltage and/or current applied between the first electrode 116 and the second electrode 118 or (ii) maintaining the voltage between the first electrode 116 and the second electrode 118 constant while adjusting the duration during which power is applied between the first electrode 116 and the second electrode 118 .
- the rate at which the EK solution 120 is displaced from the EK supply reservoir 110 to the EK solution receiving chamber 114 and, therefore, the rate at which the infusion liquid 130 is displaced through the infusion reservoir outlet 128 can be accurately and beneficially controlled.
- the closed loop control of EK infusion pumps described above beneficially compensates for variations that may cause inconsistent displacement (i.e., dispensing) of the infusion liquid 130 including, but not limited to, variations in temperature, downstream resistance, and mechanical friction.
- the EK supply reservoir 110 can have a variety of configurations.
- the EK supply reservoir 110 can be partially or wholly collapsible.
- the EK supply reservoir 110 can be configured as a collapsible sack.
- Such collapsibility provides for the volume of the EK supply reservoir 110 to decrease as the EK solution 120 is displaced therefrom.
- Such a collapsible EK supply reservoir 110 can also assist in the prevention of undesirable bubble formation within the EK supply reservoir 110 .
- the infusion module housing 122 can also be configured in a variety of additional ways, and can be, for example, at least partially rigid to facilitate the movement of the moveable partition 124 and the reception of the EK solution 120 pumped from the EK supply reservoir 110 .
- the moveable partition 124 can be configured to prevent migration of the EK solution 120 into the infusion liquid 130 , while minimizing resistance to its own movement (displacement) as the EK solution receiving chamber 114 receives the EK solution 120 pumped from the EK supply reservoir 110 .
- the moveable partition 124 can, for example, include elastomeric seals that provide intimate, yet movable, contact between the moveable partition 124 and the infusion module housing 122 .
- the moveable partition 124 can have a variety of configurations, such as, for example, a piston-like configuration, or the moveable partition 124 can be configured as a moveable membrane and/or bellows.
- FIG. 3 is a perspective illustration of an electrokinetic (EK) infusion pump system 200 according to another exemplary embodiment of the present invention being manipulated by a user's hands (H).
- the EK infusion pump system 200 can include an electrokinetic (EK) infusion pump 202 and a closed loop controller 204 .
- the EK infusion pump 202 and the closed loop controller 204 can be handheld, and/or mounted to a user by way of clips, adhesives or non-adhesive removable fasteners.
- the EK infusion pump system 200 can be configured to be worn on a user's belt, thereby providing an ambulatory EK infusion pump system.
- the closed loop controller 204 can be directly or wirelessly connected to a remote controller or other auxiliary equipment (not shown in FIG. 3 ) that provide analyte monitoring capabilities and/or additional data processing capabilities.
- the EK infusion pump 202 and the closed loop controller 204 can include components that are essentially equivalent to those described above with respect to the EK infusion pump 102 and the closed loop controller 104 .
- the closed loop controller 204 can include a variety of features, including a display 240 , input keys 242 a and 242 b , and an insertion port 244 .
- the display 240 can be configured, for example, to display a variety of information, including infusion rates, error messages and logbook information.
- the EK infusion pump 202 can be inserted into the insertion port 244 .
- operative electrical communication is established between the closed loop controller 204 and the EK infusion pump 202 .
- Such electrical communication includes the ability for the closed loop controller 204 to receive a feedback signal FB from a capacitive displacement position sensor of the EK infusion pump 202 and operative electrical contact with first and second electrodes of the EK infusion pump 202 .
- an infusion set (not shown but typically including, for example, a connector, tubing, needle and/or cannula and an adhesive patch) can be connected to the infusion reservoir outlet of the EK infusion pump 202 and, thereafter, primed.
- attachment and priming can occur before or after EK infusion pump 202 is inserted into insertion port 244 .
- voltage and current are applied across the EK porous media of EK infusion pump 202 , thereby dispensing (pumping) infusion liquid.
- FIG. 4 is a cross-sectional depiction of an electrokinetic (EK) infusion pump system 300 according to a further exemplary embodiment of the present invention in a first dispense state, while FIG. 5 depicts the EK infusion pump system 300 in second dispense state.
- FIG. 6 is a further perspective depiction of a portion of the EK infusion pump system 300 in the first dispense state of FIG. 4 , while FIG. 7 is in the second dispense state of FIG. 5 .
- the focus of FIGS. 6 and 7 is the capacitive displacement position sensor of the EK infusion pump system 300 . Therefore, FIGS. 6 and 7 are further simplified versions of FIGS. 4 and 5 that serve to highlight the capacitive displacement position sensor.
- the EK infusion pump system 300 includes an electrokinetic (EK) infusion pump 302 and a closed loop controller 304 .
- EK infusion pump 302 includes an integrated electrokinetic (EK) engine and infusion module (collectively element 306 ) and a capacitive displacement position sensor 307 .
- the integrated EK engine and infusion module 306 includes an electrokinetic (EK) supply reservoir 310 , an electrokinetic (EK) porous media 312 , an electrokinetic (EK) solution receiving chamber 314 , a first electrode 316 , a second electrode 318 , and an electrokinetic (EK) solution 320 (depicted as upwardly pointing chevrons).
- the integrated EK engine and infusion module 306 also includes an infusion module housing 322 , a movable partition 324 , an infusion reservoir 326 , an infusion reservoir outlet 328 , and an infusion liquid 330 (depicted as dotted shading).
- the moveable partition 324 can have a variety of configurations, but in the illustrated embodiment can include a first infusion seal 348 , a spacer 349 , and a second infusion seal 350 .
- the spacer 349 is positioned between the first and second infusion seals 348 , 350 , with the first infusion seal positioned proximal of the spacer 349 and the second infusion seal 350 positioned distal of the spacer 349 .
- the spacer 349 of the moveable partition 324 is at a position B in the first dispense state a shown in FIG. 4 , and is at a position C in the second dispense state as shown in FIG. 5 .
- the distance between position B and position C is labeled D in FIG. 5 .
- the capacitive displacement position sensor 307 includes a first capacitive element 352 , such as a capacitive plate, a second capacitive element 354 , such as a capacitive plate, a first electrical contact 356 , a second electrical contact 358 , and a capacitance measurement module 360 .
- the first capacitive plate 352 is mounted on the movable partition 324 , and moves parallel to the longitudinal axis of the infusion module housing 322 along with the movable partition 324 .
- the second capacitive plate 354 remains stationary and is mounted on the infusion module housing 322 such that there is a gap G (also referred to as a separation) between the first capacitive plate 352 and the second capacitive plate 354 .
- the gap G can be filled with any suitable material including, for example, air, a wall of the infusion module housing 322 (which is formed of plastic or other suitable electrically insulating material), other suitable electrically insulating material, and combinations thereof.
- the first electrical contact 356 provides electrical contact between the first capacitive plate 352 and the capacitance measurement module 360
- second electrical contact 358 provides electrical contact between second capacitive plate 354 and capacitance measurement module 360
- the moveable partition 324 is in a first position, and the first capacitive plate 352 partially overlaps the second capacitive plate 354
- the capacitance measurement module 360 is configured to provide a feedback signal FB to the closed loop controller 304 which is indicative of the capacitance between the first and second capacitive plates 352 , 354 .
- the closed loop controller 304 uses the feedback signal FB to control the dispense state, as will be described in more detail below.
- a measured capacitance between the first capacitive plate 352 and the second capacitive plate 354 can be readily correlated to the extent of their overlap. Since the first capacitive plate 352 is attached to the moveable partition 324 , the extent of overlap and/or any change in overlap can be employed to determine the position (i.e., displacement position) of the moveable partition 324 . For example, in FIGS. 5 and 7 , the moveable partition 324 has moved relative to its position in FIGS. 4 and 6 , and the overlap between the first capacitive plate 352 and the second capacitive plate 354 has increased. This increase in overlap will result in an increase in the capacitance that is measured by the capacitance measurement module 360 .
- the position of the movable partition 324 can then be readily derived from the change in capacitance between the two capacitive plates 352 , 354 since the measured capacitance C is proportional to A/G where A is the area of plate overlap and G is the gap dimension.
- the first and second capacitive plates 352 , 354 have typical dimensions, for example, of 10 mm (width) by 20 mm (length).
- the area of overlap between the first and second capacitive plates 352 , 354 can vary depending on the placement of the first and second capacitive plates 352 , 354 on the moveable partition 324 and the infusion module housing 322 .
- the largest overlap between the first and second capacitive plates 352 , 354 can be a substantially complete overlap of the first and second capacitive plates 352 , 354 , and the smallest overlap between the first and second capacitive plates 352 , 354 has typical dimensions, for example, of 10 mm (in width) by 5 mm (in length).
- the gap dimension G can have a range between 10 and 1000 micrometers, and, for example, it can be 0.5 mm.
- FIG. 8 is a perspective depiction of a portion of an electrokinetic (EK) infusion pump 400 according to another embodiment of the present invention in a first dispense state.
- EK electrokinetic
- FIG. 9 is a perspective depiction of the portion of the EK infusion pump 400 in a second dispense state.
- FIGS. 8 and 9 are simplified in a similar manner to the simplified depictions of FIGS. 6 and 7 .
- FIG. 10 is a schematic drawing depicting a capacitive plate configuration 500 of the first dispense state of FIG. 8
- FIG. 11 is a schematic drawing depicting a capacitive plate configuration 600 of the second dispense state of FIG. 9 .
- the EK infusion pump 400 includes an integrated electrokinetic (EK) engine and infusion module 406 , and a dual capacitive displacement sensor 407 .
- the integrated EK engine and infusion module 406 includes an infusion module housing 422 and a moveable partition 424 .
- the dual capacitive displacement sensor 407 includes a first capacitive plate 482 , a second capacitive plate 484 (configured as an extension of first capacitive plate 482 ), a third capacitive plate 486 , a fourth capacitive plate 488 , a first electrical contact 490 , and a second electrical contact 492 .
- the first and second capacitive plates 482 , 484 are mounted on the movable partition 424 , and move parallel to the longitudinal axis of the infusion module housing 422 together with the movable partition 424 (for example, in the direction of arrow A 6 as shown in FIG. 11 ).
- the third and fourth capacitive plates 486 , 488 are mounted on the infusion module housing 422 such that there is a gap between the first capacitive plate 482 and the third capacitive plate 486 , as well as a gap between the second capacitive plate 484 and the fourth capacitive plate 488 .
- the gaps can be filled with any suitable material including, for example, air, a wall of the infusion module housing 422 (which is formed of plastic or other suitable electrically insulating material), other suitable electrically insulating material, and combinations thereof.
- the first electrical contact 490 provides electrical contact between the fourth capacitive plate 488 and the capacitance measurement module 460
- the second electrical contact 492 provides electrical contact between the third capacitive plate 486 and the capacitance measurement module 460 .
- the extent of overlap between the first capacitive plate 482 and the third capacitive plate 486 is variable as the moveable partition 424 moves, as evidenced by a comparison of FIGS. 8 and 9 or FIGS. 10 and 11 .
- the extent of overlap between the second capacitive plate 484 and the fourth capacitive plate 488 is constant as moveable partition 424 moves, as evidenced by a comparison of FIGS. 8 and 9 or FIGS. 10 and 11 .
- the position of the movable partition 424 can then be derived from a change in capacitance as measured by the capacitance measurement module 460 .
- the position of the moveable partition 424 can be readily derived since the total measured capacitance is the result of two capacitances in series, of which one is constant and one is variable with moveable partition position.
- 1/C tot is equal to the sum of 1/C c and 1/C v (where C tot is the measured total capacitance, C c is the constant capacitance between the second and fourth capacitive plates 484 , 488 and C v is the variable capacitance between first and third capacitive plates 482 , 486 ).
- FIG. 12 is an electrical circuit schematic depicting an electric circuit 700 that is essentially equivalent to the circuit formed by the capacitive plates depicted in FIGS. 8-11 .
- the circuit includes one variable capacitor that includes the first and third capacitive plates (i.e., capacitive plates 482 and 486 ) and one fixed capacitor that includes the second and third capacitive plates (i.e., capacitive plates 484 and 488 ).
- FIG. 13 is a flow diagram illustrating a method 800 for the closed loop control of an electrokinetic (EK) infusion pump according to an exemplary embodiment of the present invention.
- the method 800 includes, at step 810 , sensing a dispensing state of an EK infusion pump with a capacitive displacement position sensor.
- the capacitive displacement position sensor and the EK infusion pump can be any such sensor and EK infusion pump as described herein with respect to embodiments of the present invention.
- the sensed dispensing state of the EK infusion pump is signaled to a closed loop controller via a feedback signal, as set forth in step 820 .
- the closed loop controller determines the dispensing state of the electrokinetic infusion pump based on the feedback signal, as set forth in step 830 .
- the dispensing state of the EK infusion pump (e.g., infusion liquid displacement rate) is controlled by the closed loop controller by the sending command signals from the closed loop controller to an electrokinetic engine of the EK infusion pump.
- the command signal can be, for example, based on a comparison of the determined dispensing state and a predetermined desired dispensing state and be a command signal that adjusts for any differences between the determined dispensing state and the predetermined desired dispensing state.
- the method 800 can be practiced using EK infusion pump systems according to the present invention including the embodiments of FIGS. 1-12 . Moreover, steps 810 through 840 can be repeated as necessary to establish and maintain accurate control of the EK infusion pump dispensing state.
- EK infusion pumps and EK infusion pump systems are economical to manufacture since the capacitive plates of their capacitive displacement position sensors can be formed using conventional economical techniques such as laser ablation of thin metal layers, screen printing and offset printing. Moreover, since the plates can be manufactured economically, the capacitive displacement position sensors described herein can be included as a component within a disposable EK infusion pump.
- capacitance can be measured using techniques with beneficially low power consumption, thus enabling EK infusion pumps and EK infusion systems with extended lifetimes.
- capacitance-to-digital converter device AD7745 commercially available from Analog Devices Inc., U.S.A.
- AD7745 can directly measure capacitance and convert the measured capacitance to a digital signal at an indicated power consumption of approximately 1 mW.
Abstract
Various methods and devices are provided for an electrokinetic infusion pump. In one embodiment of the invention, the infusion pump includes an infusion pump module, which can be configured to dispense an insulin containing infusion liquid, and an electrokinetic engine. The infusion pump module includes a capacitive displacement position sensor configured for sensing a dispensing state of the infusion pump module. The infusion pump module can include an infusion module housing and the electrokinetic engine can include a moveable partition. The capacitive displacement sensor includes a first capacitive plate disposed on the moveable partition and a second capacitive plate disposed on the infusion module housing. The capacitive displacement sensor is configured for measuring capacitance between the first capacitive plate and the second capacitive plate and can send a feedback signal to a closed loop controller that is indicative of the capacitance between the first and second capacitive plates.
Description
- The present invention relates, in general, to a medical devices and systems and, in particular, to infusion pumps, infusion pump systems and associated methods.
- Electrokinetic (EK) pumps provide for liquid displacement by applying an electric potential across a porous dielectric media that is filled with an ion-containing electrokinetic solution. Properties of the porous dielectric media and ion-containing solution (e.g., permittivity of the ion-containing solution and zeta potential of the solid-liquid interface between the porous dielectric media and the ion-containing solution) are predetermined such that an electrical double-layer is formed at the solid-liquid interface. Thereafter, ions of the electrokinetic solution within the electrical double-layer migrate in response to the electric potential, transporting the bulk electrokinetic solution with them via viscous interaction. The resulting electrokinetic flow (also known as electroosmotic flow) of the bulk electrokinetic solution is employed to displace (i.e., “pump”) a liquid. Further details regarding electrokinetic pumps, including materials, designs, and methods of manufacturing are included in U.S. patent application Ser. No. 10/322,083 (United States Published Application No. 2004/0074784) filed on Dec. 17, 2002, which is hereby incorporated in full by reference.
- The present invention provides various methods and devices for an electrokinetic infusion pump. In one embodiment, the electrokinetic infusion pump includes an infusion pump module, which can be configured to dispense a medicament or another treatment agent (e.g., an insulin containing infusion liquid), and an electrokinetic engine. The infusion pump module includes a capacitive displacement position sensor configured for sensing a dispensing state of the infusion pump module. The infusion pump module can include an infusion module housing and the electrokinetic engine can include a moveable partition. The capacitive displacement sensor includes a first capacitive element, such as a capacitive plate, disposed on the moveable partition and a second element, such as a capacitive plate, disposed on the infusion module housing. The capacitive displacement sensor is configured for measuring capacitance between the first capacitive element and the second capacitive element and can send a feedback signal to a closed loop controller that is indicative of the capacitance between the first and second capacitive plates. In one exemplary embodiment, the first capacitive plate and the second capacitive plate each have a width of approximately 10 mm and a length of approximately 20 mm. A gap between the first capacitive plate and the second capacitive plate can have a dimension in the range of approximately 10-1000 micrometers.
- In another embodiment, the electrokinetic engine includes a moveable partition and the infusion pump includes an infusion housing, and the capacitive displacement sensor is a dual capacitive displacement sensor. The dual capacitive displacement sensor includes a first capacitive plate and a second capacitive plate disposed on the moveable partition and a third capacitive plate and a fourth capacitive plate disposed on the infusion housing. The first, second, third, and fourth capacitive plates are in operative electrical contact. An overlap between the second and fourth capacitive plate is constant and an overlap between the first capacitive plate and the third capacitive plate is dependent on a position of the moveable partition.
- In another exemplary embodiment, an infusion pump system is provided that includes an infusion pump, for example, an electrokinetic pump, having a capacitive displacement position sensor and a closed loop controller. The infusion pump and closed loop controller are in operative communication and configured such that the closed loop controller can determine and control a dispensing state of the infusion pump based on a feedback signal received from the capacitive displacement position sensor. The infusion pump further includes an infusion pump module and an electrokinetic engine. The capacitive displacement sensor is configured for sensing a dispensing state of the infusion pump module. The infusion pump can be configured to dispense, for example, an insulin-containing infusion liquid.
- The infusion pump module can include an infusion module housing and the electrokinetic engine can include a moveable partition. The electrokinetic engine can also include an electrokinetic supply reservoir that is at least partially collapsible. The capacitive displacement sensor can include a first capacitive plate disposed on the moveable partition and a second capacitive plate disposed on the infusion module housing, and the capacitive displacement sensor can be configured for sensing a dispensing state by measuring capacitance between the first capacitive plate and the second capacitive plate. In one embodiment, the first capacitive plate and the second capacitive plate each have a width of approximately 10 mm and a length of approximately 20 mm, and a gap between the first capacitive plate and the second capacitive plate has a dimension in the range of approximately 10-1000 micrometer.
- In one embodiment, the electrokinetic engine includes a moveable partition and the capacitive displacement sensor is a dual capacitive displacement sensor that includes first, second, third, and fourth capacitive plates. The first, second, third, and fourth capacitive plates are in operative electrical contact and an overlap between the second and fourth capacitive plate is constant and an overlap between the first capacitive plate and the third capacitive plate is dependent on a position of the moveable partition.
- Methods for the closed loop control of an infusion pump are also provided, and in one embodiment the method can include sensing a dispensing state of an infusion pump, for example, an electrokinetic infusion pump, with a capacitive displacement position sensor and signaling the sensed dispensing state of the infusion pump to a closed loop controller via a feedback signal. The closed loop controller determines the dispensing state of the infusion pump based feedback signal and controls the dispensing state of the infusion pump by sending command signals from the closed loop controller to an engine driving the infusion pump. These steps can be repeated to maintain control of the electrokinetic infusion pump.
- Sensing the dispensing state can include sensing a position of a moveable partition of the electrokinetic infusion pump by the capacitive displacement sensor. Sensing the dispensing state can also include sensing the position of the moveable partition due to a change in overlap between capacitive plates of the capacitive displacement sensor. The dispensing state can be an infusion liquid displacement rate or an infusion liquid volume. The step of controlling the dispensing state can include controlling the dispensing state of an insulin containing infusion liquid. The capacitive displacement position sensor can be a dual capacitive displacement sensor.
- The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
-
FIG. 1 is an exploded schematic illustration of an electrokinetic infusion pump system with closed loop control according to an exemplary embodiment of the present invention in a first dispense state; -
FIG. 2 is an exploded schematic illustration of the electrokinetic infusion pump system shown inFIG. 1 in a second dispense state; -
FIG. 3 is a perspective illustration of an electrokinetic infusion pump system according to another exemplary embodiment of the present invention being manually manipulated; -
FIG. 4 is a cross-sectional depiction of an electrokinetic infusion pump system according to a further exemplary embodiment of the present invention in a first dispense state; -
FIG. 5 is a cross-sectional depiction of the electrokinetic infusion pump system shown inFIG. 4 in a second dispense state; -
FIG. 6 is a perspective depiction of a portion of the electrokinetic infusion pump of the EK infusion pump system shown inFIG. 4 ; -
FIG. 7 is a perspective depiction of a portion of the electrokinetic infusion pump of the EK infusion pump system shown inFIG. 5 ; -
FIG. 8 is a perspective depiction of a portion of an electrokinetic infusion pump with capacitive displacement position sensors according to another exemplary embodiment of the present invention in a first dispense state; -
FIG. 9 is a perspective depiction of the portion of an electrokinetic infusion pump shown inFIG. 8 in a second dispense state; -
FIG. 10 is a schematic drawing depicting a capacitive plate configuration of the electrokinetic infusion pump shown inFIG. 8 ; -
FIG. 11 is a schematic drawing depicting a capacitive plate configuration of the electrokinetic infusion pump shown inFIG. 9 ; -
FIG. 12 is an electrical circuit schematic depicting the analog electric circuit formed by the capacitive displacement position sensor shown inFIGS. 8-11 ; and -
FIG. 13 is a flow diagram illustrating a method for the closed loop control of an electrokinetic infusion pump according to an exemplary embodiment of the present invention. - Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present invention is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present invention.
- Various exemplary methods and devices are provided for controlling the dispensing state of an infusion pump system. In particular, the methods and devices provide a capacitive displacement position sensor coupled with an infusion pump to control the dispensing of an infusion liquid from the infusion pump.
-
FIGS. 1-2 are exploded schematic illustrations of an electrokinetic (EK)infusion pump system 100 with closed loop control according to an exemplary embodiment of the present invention.FIG. 1 . illustrates the EKinfusion pump system 100 in a first dispense state, whileFIG. 2 depicts the EKinfusion pump system 100 in a second dispense state. - Referring to
FIGS. 1 and 2 , the EKinfusion pump system 100 includes an electrokinetic (EK)infusion pump 102 and aclosed loop controller 104. TheEK infusion pump 102 can include a capacitive displacement position sensor (not shown inFIGS. 1 and 2 ). As is described in further detail below, theEK infusion pump 102 and theclosed loop controller 104 are in operative communication such that theclosed loop controller 104 can determine and control the dispensing state of theEK infusion pump 102 based on one or more feedback signals FB from the capacitive displacement position sensor. TheEK infusion pump 102 and theclosed loop controller 104 can be configured in a variety of ways. For example, theinfusion pump 102 and theclosed loop controller 104 can be entirely separate units, partially integrated (for example, predetermined components of theEK infusion pump 102 can be integrated within the closed loop controller 104), or a single integrated unit. - The EK infusion pump systems according to embodiments of the present invention, including the EK
infusion pump system 100, can be employed to deliver a variety of medically useful infusion liquids such as, for example, insulin for diabetes; morphine and other analgesics for pain; barbiturates and ketamine for anesthesia; anti-infective and antiviral therapies for Acquired Immune Deficiency Syndrome (AIDS); antibiotic therapies for preventing infection; bone marrow for immunodeficiency disorders, blood-borne malignancies, and solid tumors; chemotherapy for cancer; dobutamine for congestive heart failure; monoclonal antibodies and vaccines for cancer, brain natriuretic peptide for congestive heart failure, and vascular endothelial growth factor for preeclampsia. The delivery of such infusion liquids can be accomplished via any suitable route including subcutaneously, intravenously or intraspinally. - The
EK infusion pump 102 can also include an electrokinetic (EK)engine 106 and aninfusion module 108. TheEK engine 106 can include an electrokinetic (EK)supply reservoir 110, an electrokinetic (EK)porous media 112, an electrokinetic (EK)solution receiving chamber 114, afirst electrode 116, asecond electrode 118, and an electrokinetic (EK) solution 120 (depicted as upwardly pointing chevrons). - The pore size of the
porous media 112 can be, for example, in the range of 100 nm to 200 nm. A person skilled in the art will appreciate that theporous media 112 can have any number of pores with any pore size that allows the appropriate amount ofelectrokinetic solution 120 to flow through it. Moreover, theporous media 112 can be formed of any suitable material including, by way of non-limiting example, Durapore Z PVDF membrane material available from Millipore, Inc. USA.EK solution 120 can be any suitable EK solution including, but not limited to, 10 mM TRIS/HCl at a neutral pH. - The
infusion module 108 can include the EK solution receiving chamber 114 (which is also considered part of the EK engine 106), aninfusion module housing 122, amovable partition 124, aninfusion reservoir 126, aninfusion reservoir outlet 128, and an infusion liquid 130 (depicted as dotted shading). Although the capacitive displacement position sensor of theinfusion module 108 is not depicted inFIGS. 1 and 2 , the feedback signal FB between the capacitive displacement position sensor and theclosed loop controller 104 is shown. - The
closed loop controller 104 can include avoltage source 132 and is configured to receive the feedback signal FB from the capacitive displacement sensor and to be in electrical communication with the first andsecond electrodes EK engine 106, theinfusion module 108, and theclosed loop controller 104 can be integrated into a single assembly, into multiple assemblies, or can be separate units. - During operation of the EK
infusion pump system 100, theEK engine 106 provides the driving force for displacing (pumping) the infusion liquid 130 from theinfusion module 108. To do so, a voltage difference is established across the EKporous media 112 by the application of an electrical potential between thefirst electrode 116 and thesecond electrode 118. This electrical potential results in an electrokinetic pumping of theEK solution 120 from theEK supply reservoir 110, through the EKporous media 112, and into the EKsolution receiving chamber 114. - As the electrokinetic
solution receiving chamber 114 receives theEK solution 120, themoveable partition 124 is forced to move in the direction of arrows μl, shown inFIGS. 1-2 . Such movement is evident by a comparison of the first dispense state shown inFIG. 1 to the second dispense state shown inFIG. 2 . As themoveable partition 124 moves in the direction of μl, theinfusion liquid 130 is displaced (i.e., “pumped”) out of theinfusion reservoir 126 and through theinfusion reservoir outlet 128 in the direction of arrow μl. TheEK engine 106 can continue to displace theEK solution 120 until themoveable partition 124 reaches a predetermined point near theinfusion reservoir outlet 128, for example, a point just proximal of theinfusion reservoir outlet 128, thereby displacing a predetermined amount (e.g., essentially all) of the infusion liquid 130 from theinfusion reservoir 126. - It is evident from the description above and a comparison of
FIGS. 1 and 2 , that the second dispensing state represented byFIG. 2 is achieved by electrokinetically displacing (i.e., pumping or dispelling) a portion of theinfusion liquid 130 that is present within theinfusion reservoir 126 in the first dispensing state represented byFIG. 1 . - The rate of displacement of the infusion liquid 130 from the
infusion reservoir 126 is directly proportional to the rate at which theEK solution 120 is pumped from theEK supply reservoir 110 into the EKsolution receiving chamber 114. The proportionality between the rate of displacement of the infusion liquid 130 (such as an insulin containing infusion liquid) and the rate at which theEK solution 120 is pumped can be, for example, in the range of 1:1 to 4:1. Furthermore, the rate at which theEK solution 120 is pumped from theEK supply reservoir 110 is a function of the voltage and current applied by thefirst electrode 116 and thesecond electrode 118 and various electro-physical properties of the EKporous media 112 and the EK solution 120 (such as, for example, zeta potential, permittivity of the EK solution and viscosity of the EK solution). - The features disclosed herein are applicable to a variety of electrokinetic infusion pump systems, including, for example, the electrokinetic infusion pumps and electrokinetic infusion pump systems of the type disclosed in U.S. patent application Ser. No. 11/532,587, filed Sep. 18, 2006, entitled “Electrokinetic Infusion Pump System,” which is incorporated herein in its entirety. In addition, features disclosed herein can be used in combination with electrokinetic infusion pump systems of the type disclosed in U.S. patent application Ser. No. 11/532,587, as well as with features of electrokinetic infusion pumps as disclosed in U.S. patent application Ser. No. 11/532,691, filed Sep. 18, 2006, entitled “Malfunction Detection With Derivative Calculation,” and U.S. patent application Ser. No. 11/614,211, filed Dec. 21, 2006, entitled “Malfunction Detection In Infusion Pumps,” both of which are likewise incorporated herein in their entirety.
- Further details regarding EK engines, including materials, designs, operation and methods of manufacturing, are included in U.S. patent application Ser. No. 10/322,083 (United States Published Application No. 2004/0074784) filed on Dec. 17, 2002, which has been incorporated by reference. Although a particular EK engine is depicted in a simplified manner in
FIGS. 1 and 2 , any suitable EK engine can be employed in embodiments of the present invention including, but not limited to, the EK engines described in the aforementioned U.S. patent application Ser. No. 10/322,083 and EK engines that substitute a media with a microchannel(s) for the aforementioned porous media. - The capacitive displacement position sensor of
EK infusion pump 102 is configured to sense (determine) the position of themoveable partition 124. Based on the sensed position of the moveable partition 124 (as communicated by feedback signal FB), theclosed loop controller 104 can determine the dispensing state (e.g., the displacement position of themoveable partition 124 at any given time and/or as a function of time, the rate of displacement of the infusion liquid 130 frominfusion reservoir 126, the rate at which theEK solution 120 is pumped from theEK supply reservoir 110 to the EKsolution receiving chamber 114, and the volume of dispensed EK solution). - Based on such a determination of dispensing state, the
closed loop controller 104 controls (i.e., can command and manage) the dispensing state by, for example, (i) adjusting the voltage and/or current applied between thefirst electrode 116 and thesecond electrode 118 or (ii) maintaining the voltage between thefirst electrode 116 and thesecond electrode 118 constant while adjusting the duration during which power is applied between thefirst electrode 116 and thesecond electrode 118. For example, by adjusting the voltage and/or current applied across thefirst electrode 116 and thesecond electrode 118, the rate at which theEK solution 120 is displaced from theEK supply reservoir 110 to the EKsolution receiving chamber 114 and, therefore, the rate at which theinfusion liquid 130 is displaced through theinfusion reservoir outlet 128, can be accurately and beneficially controlled. - The closed loop control of EK infusion pumps described above beneficially compensates for variations that may cause inconsistent displacement (i.e., dispensing) of the
infusion liquid 130 including, but not limited to, variations in temperature, downstream resistance, and mechanical friction. - The
EK supply reservoir 110 can have a variety of configurations. In one embodiment, theEK supply reservoir 110 can be partially or wholly collapsible. For example, theEK supply reservoir 110 can be configured as a collapsible sack. Such collapsibility provides for the volume of theEK supply reservoir 110 to decrease as theEK solution 120 is displaced therefrom. Such a collapsibleEK supply reservoir 110 can also assist in the prevention of undesirable bubble formation within theEK supply reservoir 110. - The
infusion module housing 122 can also be configured in a variety of additional ways, and can be, for example, at least partially rigid to facilitate the movement of themoveable partition 124 and the reception of theEK solution 120 pumped from theEK supply reservoir 110. - The
moveable partition 124 can be configured to prevent migration of theEK solution 120 into theinfusion liquid 130, while minimizing resistance to its own movement (displacement) as the EKsolution receiving chamber 114 receives theEK solution 120 pumped from theEK supply reservoir 110. Themoveable partition 124 can, for example, include elastomeric seals that provide intimate, yet movable, contact between themoveable partition 124 and theinfusion module housing 122. Themoveable partition 124 can have a variety of configurations, such as, for example, a piston-like configuration, or themoveable partition 124 can be configured as a moveable membrane and/or bellows. -
FIG. 3 is a perspective illustration of an electrokinetic (EK)infusion pump system 200 according to another exemplary embodiment of the present invention being manipulated by a user's hands (H). The EKinfusion pump system 200 can include an electrokinetic (EK)infusion pump 202 and aclosed loop controller 204. - The
EK infusion pump 202 and theclosed loop controller 204 can be handheld, and/or mounted to a user by way of clips, adhesives or non-adhesive removable fasteners. For example, the EKinfusion pump system 200 can be configured to be worn on a user's belt, thereby providing an ambulatory EK infusion pump system. In addition, theclosed loop controller 204 can be directly or wirelessly connected to a remote controller or other auxiliary equipment (not shown inFIG. 3 ) that provide analyte monitoring capabilities and/or additional data processing capabilities. - The
EK infusion pump 202 and theclosed loop controller 204 can include components that are essentially equivalent to those described above with respect to theEK infusion pump 102 and theclosed loop controller 104. In addition, theclosed loop controller 204 can include a variety of features, including adisplay 240,input keys insertion port 244. - The
display 240 can be configured, for example, to display a variety of information, including infusion rates, error messages and logbook information. During use of the EKinfusion pump system 200, and subsequent to theEK infusion pump 202 having been filled with infusion liquid, theEK infusion pump 202 can be inserted into theinsertion port 244. Upon such insertion, operative electrical communication is established between theclosed loop controller 204 and theEK infusion pump 202. Such electrical communication includes the ability for theclosed loop controller 204 to receive a feedback signal FB from a capacitive displacement position sensor of theEK infusion pump 202 and operative electrical contact with first and second electrodes of theEK infusion pump 202. - One skilled in the art will recognize that an infusion set (not shown but typically including, for example, a connector, tubing, needle and/or cannula and an adhesive patch) can be connected to the infusion reservoir outlet of the
EK infusion pump 202 and, thereafter, primed. As may be suitable for a particular infusion set, such attachment and priming can occur before or afterEK infusion pump 202 is inserted intoinsertion port 244. After determining the position of a movable partition ofEK infusion pump 202, voltage and current are applied across the EK porous media ofEK infusion pump 202, thereby dispensing (pumping) infusion liquid. -
FIG. 4 is a cross-sectional depiction of an electrokinetic (EK)infusion pump system 300 according to a further exemplary embodiment of the present invention in a first dispense state, whileFIG. 5 depicts the EKinfusion pump system 300 in second dispense state.FIG. 6 is a further perspective depiction of a portion of the EKinfusion pump system 300 in the first dispense state ofFIG. 4 , whileFIG. 7 is in the second dispense state ofFIG. 5 . As will be evident from the discussion below, the focus ofFIGS. 6 and 7 is the capacitive displacement position sensor of the EKinfusion pump system 300. Therefore,FIGS. 6 and 7 are further simplified versions ofFIGS. 4 and 5 that serve to highlight the capacitive displacement position sensor. - Referring to
FIGS. 4-7 , the EKinfusion pump system 300 includes an electrokinetic (EK)infusion pump 302 and aclosed loop controller 304. As will be clear to one skilled in the art from the following description, theEK infusion pump 302 includes an integrated electrokinetic (EK) engine and infusion module (collectively element 306) and a capacitivedisplacement position sensor 307. - The integrated EK engine and
infusion module 306 includes an electrokinetic (EK)supply reservoir 310, an electrokinetic (EK)porous media 312, an electrokinetic (EK)solution receiving chamber 314, afirst electrode 316, asecond electrode 318, and an electrokinetic (EK) solution 320 (depicted as upwardly pointing chevrons). The integrated EK engine andinfusion module 306 also includes aninfusion module housing 322, amovable partition 324, aninfusion reservoir 326, aninfusion reservoir outlet 328, and an infusion liquid 330 (depicted as dotted shading). - The
moveable partition 324 can have a variety of configurations, but in the illustrated embodiment can include afirst infusion seal 348, aspacer 349, and asecond infusion seal 350. Thespacer 349 is positioned between the first and second infusion seals 348, 350, with the first infusion seal positioned proximal of thespacer 349 and thesecond infusion seal 350 positioned distal of thespacer 349. Thespacer 349 of themoveable partition 324 is at a position B in the first dispense state a shown inFIG. 4 , and is at a position C in the second dispense state as shown inFIG. 5 . The distance between position B and position C is labeled D inFIG. 5 . - In an exemplary embodiment, the capacitive
displacement position sensor 307 includes a firstcapacitive element 352, such as a capacitive plate, a secondcapacitive element 354, such as a capacitive plate, a firstelectrical contact 356, a secondelectrical contact 358, and acapacitance measurement module 360. - The
first capacitive plate 352 is mounted on themovable partition 324, and moves parallel to the longitudinal axis of theinfusion module housing 322 along with themovable partition 324. Thesecond capacitive plate 354 remains stationary and is mounted on theinfusion module housing 322 such that there is a gap G (also referred to as a separation) between thefirst capacitive plate 352 and thesecond capacitive plate 354. The gap G can be filled with any suitable material including, for example, air, a wall of the infusion module housing 322 (which is formed of plastic or other suitable electrically insulating material), other suitable electrically insulating material, and combinations thereof. - The first
electrical contact 356 provides electrical contact between thefirst capacitive plate 352 and thecapacitance measurement module 360, while secondelectrical contact 358 provides electrical contact between secondcapacitive plate 354 andcapacitance measurement module 360. In the first dispense state depicted inFIGS. 4 and 6 , themoveable partition 324 is in a first position, and thefirst capacitive plate 352 partially overlaps thesecond capacitive plate 354. Thecapacitance measurement module 360 is configured to provide a feedback signal FB to theclosed loop controller 304 which is indicative of the capacitance between the first and secondcapacitive plates moveable partition 324 and thefirst capacitive plate 354 move and the capacitance between the first and secondcapacitive plates closed loop controller 304 uses the feedback signal FB to control the dispense state, as will be described in more detail below. - As the capacitance between two capacitive plates is proportional to their overlapping area divided by the distance between the plates, a measured capacitance between the
first capacitive plate 352 and thesecond capacitive plate 354 can be readily correlated to the extent of their overlap. Since thefirst capacitive plate 352 is attached to themoveable partition 324, the extent of overlap and/or any change in overlap can be employed to determine the position (i.e., displacement position) of themoveable partition 324. For example, inFIGS. 5 and 7 , themoveable partition 324 has moved relative to its position inFIGS. 4 and 6 , and the overlap between thefirst capacitive plate 352 and thesecond capacitive plate 354 has increased. This increase in overlap will result in an increase in the capacitance that is measured by thecapacitance measurement module 360. - The position of the
movable partition 324 can then be readily derived from the change in capacitance between the twocapacitive plates capacitive plates capacitive plates capacitive plates moveable partition 324 and theinfusion module housing 322. For example, the largest overlap between the first and secondcapacitive plates capacitive plates capacitive plates - In the embodiments shown in
FIGS. 4-7 , both the first and secondcapacitive plates capacitance measurement module 360. However, providing a direct electrical connection to thefirst capacitive plate 352 can raise the cost and complexity of manufacturing.FIG. 8 is a perspective depiction of a portion of an electrokinetic (EK)infusion pump 400 according to another embodiment of the present invention in a first dispense state. As is explained in more detail below, theEK infusion pump 400 employs a dual capacitive coupling configuration to address the issue of manufacturing cost and complexity.FIG. 9 is a perspective depiction of the portion of theEK infusion pump 400 in a second dispense state.FIGS. 8 and 9 are simplified in a similar manner to the simplified depictions ofFIGS. 6 and 7 . -
FIG. 10 is a schematic drawing depicting acapacitive plate configuration 500 of the first dispense state ofFIG. 8 , whileFIG. 11 is a schematic drawing depicting acapacitive plate configuration 600 of the second dispense state ofFIG. 9 . - Referring to
FIGS. 8-11 , theEK infusion pump 400 includes an integrated electrokinetic (EK) engine andinfusion module 406, and a dualcapacitive displacement sensor 407. The integrated EK engine andinfusion module 406 includes aninfusion module housing 422 and amoveable partition 424. - The dual
capacitive displacement sensor 407 includes afirst capacitive plate 482, a second capacitive plate 484 (configured as an extension of first capacitive plate 482), athird capacitive plate 486, afourth capacitive plate 488, a firstelectrical contact 490, and a secondelectrical contact 492. - The first and second
capacitive plates movable partition 424, and move parallel to the longitudinal axis of theinfusion module housing 422 together with the movable partition 424 (for example, in the direction of arrow A6 as shown inFIG. 11 ). The third and fourthcapacitive plates infusion module housing 422 such that there is a gap between thefirst capacitive plate 482 and thethird capacitive plate 486, as well as a gap between thesecond capacitive plate 484 and thefourth capacitive plate 488. The gaps can be filled with any suitable material including, for example, air, a wall of the infusion module housing 422 (which is formed of plastic or other suitable electrically insulating material), other suitable electrically insulating material, and combinations thereof. - The first
electrical contact 490 provides electrical contact between thefourth capacitive plate 488 and thecapacitance measurement module 460, while the secondelectrical contact 492 provides electrical contact between thethird capacitive plate 486 and thecapacitance measurement module 460. - The extent of overlap between the
first capacitive plate 482 and thethird capacitive plate 486 is variable as themoveable partition 424 moves, as evidenced by a comparison ofFIGS. 8 and 9 orFIGS. 10 and 11 . However, the extent of overlap between thesecond capacitive plate 484 and thefourth capacitive plate 488 is constant asmoveable partition 424 moves, as evidenced by a comparison ofFIGS. 8 and 9 orFIGS. 10 and 11 . The position of themovable partition 424 can then be derived from a change in capacitance as measured by thecapacitance measurement module 460. The position of themoveable partition 424 can be readily derived since the total measured capacitance is the result of two capacitances in series, of which one is constant and one is variable with moveable partition position. In other words, 1/Ctot is equal to the sum of 1/Cc and 1/Cv (where Ctot is the measured total capacitance, Cc is the constant capacitance between the second and fourthcapacitive plates capacitive plates 482, 486). -
FIG. 12 is an electrical circuit schematic depicting anelectric circuit 700 that is essentially equivalent to the circuit formed by the capacitive plates depicted inFIGS. 8-11 . As depicted inFIG. 12 , the circuit includes one variable capacitor that includes the first and third capacitive plates (i.e.,capacitive plates 482 and 486) and one fixed capacitor that includes the second and third capacitive plates (i.e.,capacitive plates 484 and 488). -
FIG. 13 is a flow diagram illustrating amethod 800 for the closed loop control of an electrokinetic (EK) infusion pump according to an exemplary embodiment of the present invention. Themethod 800 includes, atstep 810, sensing a dispensing state of an EK infusion pump with a capacitive displacement position sensor. The capacitive displacement position sensor and the EK infusion pump can be any such sensor and EK infusion pump as described herein with respect to embodiments of the present invention. - Subsequently, the sensed dispensing state of the EK infusion pump is signaled to a closed loop controller via a feedback signal, as set forth in
step 820. The closed loop controller then determines the dispensing state of the electrokinetic infusion pump based on the feedback signal, as set forth instep 830. - Subsequently, at
step 840, the dispensing state of the EK infusion pump (e.g., infusion liquid displacement rate) is controlled by the closed loop controller by the sending command signals from the closed loop controller to an electrokinetic engine of the EK infusion pump. The command signal can be, for example, based on a comparison of the determined dispensing state and a predetermined desired dispensing state and be a command signal that adjusts for any differences between the determined dispensing state and the predetermined desired dispensing state. - The
method 800 can be practiced using EK infusion pump systems according to the present invention including the embodiments ofFIGS. 1-12 . Moreover, steps 810 through 840 can be repeated as necessary to establish and maintain accurate control of the EK infusion pump dispensing state. - EK infusion pumps and EK infusion pump systems according to embodiments of the present invention are economical to manufacture since the capacitive plates of their capacitive displacement position sensors can be formed using conventional economical techniques such as laser ablation of thin metal layers, screen printing and offset printing. Moreover, since the plates can be manufactured economically, the capacitive displacement position sensors described herein can be included as a component within a disposable EK infusion pump.
- In addition, capacitance can be measured using techniques with beneficially low power consumption, thus enabling EK infusion pumps and EK infusion systems with extended lifetimes. For example, capacitance-to-digital converter device AD7745 (commercially available from Analog Devices Inc., U.S.A.) can directly measure capacitance and convert the measured capacitance to a digital signal at an indicated power consumption of approximately 1 mW.
- It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods within the scope of these claims and their equivalents be covered thereby
- One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.
Claims (20)
1. An electrokinetic infusion pump comprising:
an infusion pump module; and
an electrokinetic engine,
wherein the infusion pump module includes a capacitive displacement position sensor configured for sensing a dispensing state of the infusion pump module.
2. The electrokinetic infusion pump of claim 1 , wherein:
the infusion pump module includes an infusion module housing;
the electrokinetic engine includes a moveable partition; and
the capacitive displacement sensor includes a first capacitive plate disposed on the moveable partition and a second capacitive plate disposed on the infusion module housing.
3. The electrokinetic infusion pump of claim 2 , wherein the first capacitive plate and the second capacitive plate each have a width of approximately 10 mm and a length of approximately 20 mm.
4. The electrokinetic infusion pump of claim 3 , wherein a gap between the first capacitive plate and the second capacitive plate has a dimension in the range of approximately 10-1000 micrometer.
5. The electrokinetic infusion pump of claim 2 , wherein the capacitive displacement sensor is configured for measuring capacitance between the first capacitive plate and the second capacitive plate.
6. The electrokinetic infusion pump of claim 1 , wherein the electrokinetic engine includes a moveable partition and the infusion pump includes an infusion housing, and wherein the capacitive displacement sensor is a dual capacitive displacement sensor that includes:
a first capacitive plate and a second capacitive plate disposed on the moveable partition; and
a third capacitive plate and a fourth capacitive plate disposed on the infusion housing;
wherein the first capacitive plate, the second capacitive plate, the third capacitive plate and the fourth capacitive plate are in operative electrical contact and wherein an overlap between the second and fourth capacitive plate is constant and an overlap between the first capacitive plate and the third capacitive plate is dependent on a position of the moveable partition.
7. The electrokinetic infusion pump of claim 1 , wherein the capacitive displacement sensor is configured to send a feedback signal to a closed loop controller, the feedback signal indicative of the capacitance between the first and second capacitive plates.
8. The electrokinetic infusion pump of claim 1 , wherein the infusion pump is configured to dispense an insulin containing infusion liquid.
9. An infusion pump system, comprising:
an infusion pump that includes:
a capacitive displacement position sensor; and
a closed loop controller,
wherein the infusion pump and closed loop controller are in operative communication and configured such that the closed loop controller can determine and control a dispensing state of the infusion pump based on a feedback signal received from the capacitive displacement position sensor.
10. The system of claim 9 , wherein the infusion pump is an electrokinetic pump.
11. The system of claim 10 , wherein the electrokinetic infusion pump further includes
an infusion pump module; and
an electrokinetic engine,
and wherein the capacitive displacement sensor is configured for sensing a dispensing state of the infusion pump module.
12. The system of claim 11 , wherein:
the infusion pump module includes an infusion module housing;
the electrokinetic engine includes a moveable partition; and
the capacitive displacement sensor includes a first capacitive plate disposed on the moveable partition and a second capacitive plate disposed on the infusion module housing.
13. The system of claim 12 , wherein the capacitive displacement sensor is configured for sensing a dispensing state by measuring capacitance between the first capacitive plate and the second capacitive plate.
14. The system of claim 13 , wherein the first capacitive plate and the second capacitive plate each have a width of approximately 10 mm and a length of approximately 20 mm.
15. The system of claim 14 , wherein a gap between the first capacitive plate and the second capacitive plate has a dimension in the range of approximately 10-1000 micrometer.
16. The system of claim 11 , wherein the electrokinetic engine includes a moveable partition and wherein the capacitive displacement sensor is a dual capacitive displacement sensor that includes:
a first capacitive plate;
a second capacitive plate;
a third capacitive plate; and
a fourth capacitive plate,
and wherein the first capacitive plate, the second capacitive plate, the third capacitive plate and the fourth capacitive plate are in operative electrical contact and wherein an overlap between the second and fourth capacitive plate is constant and an overlap between the first capacitive plate and the third capacitive plate is dependent on a position of the moveable partition.
17. The system of claim 11 , wherein the electrokinetic engine includes an electrokinetic supply reservoir that is at least partially collapsible.
18. The system of claim 9 , wherein the capacitive displacement sensor is configured to send the feedback signal to the closed loop controller.
19. The system of claim 9 , wherein the infusion pump is configured to dispense an insulin-containing infusion liquid.
20. A method for the closed loop control of an infusion pump, comprising:
sensing a dispensing state of an infusion pump with a capacitive displacement position sensor;
signaling the sensed dispensing state of the infusion pump to a closed loop controller via a feedback signal;
determining, with the closed loop controller, the dispensing state of the infusion pump based feedback signal; and
controlling the dispensing state of the infusion pump with the closed loop controller by sending command signals from the closed loop controller to an engine driving the infusion pump.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/614,364 US20080152507A1 (en) | 2006-12-21 | 2006-12-21 | Infusion pump with a capacitive displacement position sensor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/614,364 US20080152507A1 (en) | 2006-12-21 | 2006-12-21 | Infusion pump with a capacitive displacement position sensor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080152507A1 true US20080152507A1 (en) | 2008-06-26 |
Family
ID=39543055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/614,364 Abandoned US20080152507A1 (en) | 2006-12-21 | 2006-12-21 | Infusion pump with a capacitive displacement position sensor |
Country Status (1)
Country | Link |
---|---|
US (1) | US20080152507A1 (en) |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100102799A1 (en) * | 2008-10-27 | 2010-04-29 | Schnidrig Juerg | Cartridge with fill level detection |
US7875047B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901365B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7909774B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7981055B2 (en) | 2001-06-12 | 2011-07-19 | Pelikan Technologies, Inc. | Tissue penetration device |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8062231B2 (en) | 2002-04-19 | 2011-11-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8251921B2 (en) | 2003-06-06 | 2012-08-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8296918B2 (en) | 2003-12-31 | 2012-10-30 | Sanofi-Aventis Deutschland Gmbh | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
US8333710B2 (en) | 2002-04-19 | 2012-12-18 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US20120323184A1 (en) * | 2011-06-14 | 2012-12-20 | Samsung Electronics Co., Ltd. | Injector and device for detecting injection button |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8382682B2 (en) | 2002-04-19 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8556829B2 (en) | 2002-04-19 | 2013-10-15 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8979511B2 (en) | 2011-05-05 | 2015-03-17 | Eksigent Technologies, Llc | Gel coupling diaphragm for electrokinetic delivery systems |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
AT515762A1 (en) * | 2014-04-15 | 2015-11-15 | Seibersdorf Labor Gmbh | Dispensing device for dispensing liquids |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
CN105688308A (en) * | 2014-11-13 | 2016-06-22 | 上海泽生科技开发有限公司 | An injection pump control method and control unit and an injection pump |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
JP2018069054A (en) * | 2011-09-02 | 2018-05-10 | ユーエヌエル ホールディングス エルエルシーUNL Holdings LLC | Drive mechanism for drug delivery pumps with integrated status indication |
US10322231B2 (en) | 2011-09-02 | 2019-06-18 | UNL Holdings | Drive mechanism for drug delivery pumps with integrated status indication |
US10549029B2 (en) | 2011-09-02 | 2020-02-04 | Unl Holdings Llc | Drive mechanism for drug delivery pumps with integrated status indication |
JP2020036876A (en) * | 2018-07-13 | 2020-03-12 | ザイノ メディカル, エルエルシーZyno Medical, Llc | High precision syringe with removable pump unit |
US10933189B2 (en) | 2012-08-29 | 2021-03-02 | Unl Holdings Llc | Variable rate controlled delivery drive mechanisms for drug delivery pumps |
US11173244B2 (en) | 2011-09-02 | 2021-11-16 | Unl Holdings Llc | Drive mechanism for drug delivery pumps with integrated status indication |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5368571A (en) * | 1993-02-03 | 1994-11-29 | Pharmetrix Corporation | Electrochemical controlled dispensing assembly and method |
US20020177237A1 (en) * | 2001-03-26 | 2002-11-28 | Igor Shvets | Liquid droplet dispensing |
US20030167035A1 (en) * | 2002-03-01 | 2003-09-04 | Flaherty J. Christopher | Flow condition sensor assembly for patient infusion device |
US7107837B2 (en) * | 2002-01-22 | 2006-09-19 | Baxter International Inc. | Capacitance fluid volume measurement |
US20070066940A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Systems and Methods for Detecting a Partition Position in an Infusion Pump |
US20070062250A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Malfunction Detection With Derivative Calculation |
US20070062251A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Infusion Pump With Closed Loop Control and Algorithm |
US20080149599A1 (en) * | 2006-12-21 | 2008-06-26 | Lifescan, Inc. | Method for manufacturing an electrokinetic infusion pump |
US7654127B2 (en) * | 2006-12-21 | 2010-02-02 | Lifescan, Inc. | Malfunction detection in infusion pumps |
-
2006
- 2006-12-21 US US11/614,364 patent/US20080152507A1/en not_active Abandoned
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5368571A (en) * | 1993-02-03 | 1994-11-29 | Pharmetrix Corporation | Electrochemical controlled dispensing assembly and method |
US20020177237A1 (en) * | 2001-03-26 | 2002-11-28 | Igor Shvets | Liquid droplet dispensing |
US6669909B2 (en) * | 2001-03-26 | 2003-12-30 | Allegro Technologies Limited | Liquid droplet dispensing |
US7107837B2 (en) * | 2002-01-22 | 2006-09-19 | Baxter International Inc. | Capacitance fluid volume measurement |
US20030167035A1 (en) * | 2002-03-01 | 2003-09-04 | Flaherty J. Christopher | Flow condition sensor assembly for patient infusion device |
US20070066940A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Systems and Methods for Detecting a Partition Position in an Infusion Pump |
US20070062250A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Malfunction Detection With Derivative Calculation |
US20070062251A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Infusion Pump With Closed Loop Control and Algorithm |
US20070066939A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Electrokinetic Infusion Pump System |
US20070093752A1 (en) * | 2005-09-19 | 2007-04-26 | Lifescan, Inc. | Infusion Pumps With A Position Detector |
US20080149599A1 (en) * | 2006-12-21 | 2008-06-26 | Lifescan, Inc. | Method for manufacturing an electrokinetic infusion pump |
US7654127B2 (en) * | 2006-12-21 | 2010-02-02 | Lifescan, Inc. | Malfunction detection in infusion pumps |
Cited By (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8622930B2 (en) | 2001-06-12 | 2014-01-07 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7981055B2 (en) | 2001-06-12 | 2011-07-19 | Pelikan Technologies, Inc. | Tissue penetration device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8382683B2 (en) | 2001-06-12 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8641643B2 (en) | 2001-06-12 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US8206319B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9937298B2 (en) | 2001-06-12 | 2018-04-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8206317B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US8679033B2 (en) | 2001-06-12 | 2014-03-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8360991B2 (en) | 2001-06-12 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8016774B2 (en) | 2001-06-12 | 2011-09-13 | Pelikan Technologies, Inc. | Tissue penetration device |
US8343075B2 (en) | 2001-06-12 | 2013-01-01 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8337421B2 (en) | 2001-06-12 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8123700B2 (en) | 2001-06-12 | 2012-02-28 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8282577B2 (en) | 2001-06-12 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8162853B2 (en) | 2001-06-12 | 2012-04-24 | Pelikan Technologies, Inc. | Tissue penetration device |
US8216154B2 (en) | 2001-06-12 | 2012-07-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8211037B2 (en) | 2001-06-12 | 2012-07-03 | Pelikan Technologies, Inc. | Tissue penetration device |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8574168B2 (en) | 2002-04-19 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8197423B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8235915B2 (en) | 2002-04-19 | 2012-08-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9907502B2 (en) | 2002-04-19 | 2018-03-06 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7875047B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8157748B2 (en) | 2002-04-19 | 2012-04-17 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8333710B2 (en) | 2002-04-19 | 2012-12-18 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8337420B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8062231B2 (en) | 2002-04-19 | 2011-11-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8366637B2 (en) | 2002-04-19 | 2013-02-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7988644B2 (en) | 2002-04-19 | 2011-08-02 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8382682B2 (en) | 2002-04-19 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8388551B2 (en) | 2002-04-19 | 2013-03-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
US8403864B2 (en) | 2002-04-19 | 2013-03-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8414503B2 (en) | 2002-04-19 | 2013-04-09 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8430828B2 (en) | 2002-04-19 | 2013-04-30 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8491500B2 (en) | 2002-04-19 | 2013-07-23 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8496601B2 (en) | 2002-04-19 | 2013-07-30 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8556829B2 (en) | 2002-04-19 | 2013-10-15 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8562545B2 (en) | 2002-04-19 | 2013-10-22 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7901365B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8636673B2 (en) | 2002-04-19 | 2014-01-28 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7959582B2 (en) | 2002-04-19 | 2011-06-14 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7938787B2 (en) | 2002-04-19 | 2011-05-10 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9339612B2 (en) | 2002-04-19 | 2016-05-17 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8808201B2 (en) | 2002-04-19 | 2014-08-19 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7909774B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8202231B2 (en) | 2002-04-19 | 2012-06-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
US8251921B2 (en) | 2003-06-06 | 2012-08-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8296918B2 (en) | 2003-12-31 | 2012-10-30 | Sanofi-Aventis Deutschland Gmbh | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US20100102799A1 (en) * | 2008-10-27 | 2010-04-29 | Schnidrig Juerg | Cartridge with fill level detection |
US8281656B2 (en) * | 2008-10-27 | 2012-10-09 | Sensile Pat Ag | Cartridge with fill level detection |
CN101721761A (en) * | 2008-10-27 | 2010-06-09 | 森西勒Pat股份公司 | Cartouche avec detection de niveau de remplissage |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8979511B2 (en) | 2011-05-05 | 2015-03-17 | Eksigent Technologies, Llc | Gel coupling diaphragm for electrokinetic delivery systems |
US20120323184A1 (en) * | 2011-06-14 | 2012-12-20 | Samsung Electronics Co., Ltd. | Injector and device for detecting injection button |
US10918788B2 (en) | 2011-09-02 | 2021-02-16 | Unl Holdings Llc | Drive mechanism for drug delivery pumps with integrated status indication |
US10549029B2 (en) | 2011-09-02 | 2020-02-04 | Unl Holdings Llc | Drive mechanism for drug delivery pumps with integrated status indication |
US10322231B2 (en) | 2011-09-02 | 2019-06-18 | UNL Holdings | Drive mechanism for drug delivery pumps with integrated status indication |
US11173244B2 (en) | 2011-09-02 | 2021-11-16 | Unl Holdings Llc | Drive mechanism for drug delivery pumps with integrated status indication |
JP2018069054A (en) * | 2011-09-02 | 2018-05-10 | ユーエヌエル ホールディングス エルエルシーUNL Holdings LLC | Drive mechanism for drug delivery pumps with integrated status indication |
US10933189B2 (en) | 2012-08-29 | 2021-03-02 | Unl Holdings Llc | Variable rate controlled delivery drive mechanisms for drug delivery pumps |
AT515762B1 (en) * | 2014-04-15 | 2016-02-15 | Seibersdorf Labor Gmbh | Dispensing device for dispensing liquids |
AT515762A1 (en) * | 2014-04-15 | 2015-11-15 | Seibersdorf Labor Gmbh | Dispensing device for dispensing liquids |
US10369287B2 (en) | 2014-04-15 | 2019-08-06 | Siebersdorf Labor GmbH | Medication injector with capacitive fill level measurement capacity, and contact sensor |
EP3225263A4 (en) * | 2014-11-13 | 2017-12-20 | Zensun (Shanghai) Science and Technology Limited | Injection pump control method, control unit, and injection pump |
CN107427630A (en) * | 2014-11-13 | 2017-12-01 | 上海泽生科技开发股份有限公司 | Inject method for controlling pump, control unit and syringe pump |
JP2017535383A (en) * | 2014-11-13 | 2017-11-30 | ゼンスン(シャンハイ)サイエンス アンド テクノロジー カンパニー リミテッド | Syringe pump control method, control unit, and syringe pump |
CN105688308A (en) * | 2014-11-13 | 2016-06-22 | 上海泽生科技开发有限公司 | An injection pump control method and control unit and an injection pump |
JP2020036876A (en) * | 2018-07-13 | 2020-03-12 | ザイノ メディカル, エルエルシーZyno Medical, Llc | High precision syringe with removable pump unit |
US11660388B2 (en) * | 2018-07-13 | 2023-05-30 | Zyno Medical, Llc | High precision syringe with removable pump unit |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080152507A1 (en) | Infusion pump with a capacitive displacement position sensor | |
US7654127B2 (en) | Malfunction detection in infusion pumps | |
US20070062251A1 (en) | Infusion Pump With Closed Loop Control and Algorithm | |
US7944366B2 (en) | Malfunction detection with derivative calculation | |
US20070066940A1 (en) | Systems and Methods for Detecting a Partition Position in an Infusion Pump | |
JP7046913B2 (en) | Systems and methods for measuring delivered doses | |
US20110034900A1 (en) | Devices and methods for improving accuracy of fluid delivery | |
US20090112155A1 (en) | Micro Diaphragm Pump | |
CN105555336A (en) | Conformable patch pump | |
US20190275239A1 (en) | Volume Measuring Arrangement | |
US8251672B2 (en) | Electrokinetic pump with fixed stroke volume | |
US20230001080A1 (en) | Device for delivering medication to a patient | |
US20230115695A1 (en) | Airflow-based volumetric pump | |
US20180200432A1 (en) | Device for administering drug solution | |
US9278176B2 (en) | Dual plunger based systems and method for use in determining a volume in a reservoir | |
US11446436B2 (en) | Flow detector | |
US20120282112A1 (en) | Ganging electrokinetic pumps | |
US20150112305A1 (en) | Fluid transport apparatus, fluid infusing apparatus, and trouble determining method for transporting tube | |
DK2869870T3 (en) | PHARMACEUTICAL MANAGEMENT DEVICE | |
KR101970412B1 (en) | Wearable infusion pump | |
JP2023532176A (en) | drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LIFESCAN, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOHM, SEBASTIAN;REEL/FRAME:019494/0240 Effective date: 20070510 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |